Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Sensorion SA (RFM.F)

0.1255
+0.0045
+(3.72%)
As of 8:06:40 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
4,023.4970
3,335.1990
Operating Expense
28,401
28,401
22,310
27,122.8050
18,336.8090
Operating Income
-28,401
-28,401
-22,310
-23,099.3080
-15,001.6100
Net Non Operating Interest Income Expense
2,548
2,548
598
-109.7810
-135.1780
Pretax Income
-25,846
-25,846
-21,766
-23,209.0900
-15,136.7890
Tax Provision
126
126
297
--
--
Net Income Common Stockholders
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Diluted NI Available to Com Stockholders
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Basic EPS
-0.07
-0.09
-0.18
-0.29
-0.19
Diluted EPS
-0.07
-0.09
-0.18
-0.29
-0.19
Basic Average Shares
225,719.8920
283,969.1290
122,501.5380
79,837.0840
79,691.3580
Diluted Average Shares
225,719.8920
283,969.1290
122,501.5380
79,837.0840
79,691.3580
Total Operating Income as Reported
-28,401
-28,401
-22,310
-23,136.6480
-15,024.5970
Rent Expense Supplemental
77.7230
--
52.0960
32.9360
111.7470
Total Expenses
28,401
28,401
22,310
27,122.8050
18,336.8090
Net Income from Continuing & Discontinued Operation
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Normalized Income
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Interest Income
2,878
2,878
708
95.5720
53.5520
Interest Expense
251
251
109
168.0140
165.7440
Net Interest Income
2,548
2,548
598
-109.7810
-135.1780
EBIT
-25,595
-25,595
-21,657
-23,041.0760
-14,971.0450
EBITDA
-25,417
-25,417
-21,490
-22,275.1510
-14,475.5270
Reconciled Depreciation
178
178
167
765.9250
495.5180
Net Income from Continuing Operation Net Minority Interest
-25,972
-25,972
-22,063
-23,209.0900
-15,136.7890
Normalized EBITDA
-25,417
-25,417
-21,490
-22,275.1510
-14,475.5270
Tax Rate for Calcs
0.0003
0.0003
0.0003
--
--
12/31/2021 - 2/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

9969.HK InnoCare Pharma Limited
10.220
-2.85%
 
AVBP ArriVent BioPharma, Inc.
21.17
+0.43%
 
ABVX ABIVAX Société Anonyme
6.93
+2.44%
 
PHVS Pharvaris N.V.
15.83
+6.82%
 
DNTH Dianthus Therapeutics, Inc.
21.23
-1.53%
 
TYRA Tyra Biosciences, Inc.
10.09
+0.70%
 
1672.HK ASCLETIS-B
6.310
-6.24%
 
MAZE Maze Therapeutics, Inc.
7.70
-19.37%
 
MBX MBX Biosciences, Inc.
9.27
+3.11%
 
SYRE Spyre Therapeutics, Inc.
14.93
+4.99%